Albemarle (ALB) insider sells 116 shares at $95 under 10b5-1
Albemarle Corporation (ALB) reported an insider transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Albemarle Corporation (ALB) reported an insider transaction. On 10/09/2025, the company’s General Counsel & Secretary sold 116 shares of common stock at $95 per share in a transaction reported on Form 4. Following the sale, the reporting person beneficially owned 11,655 shares, held directly.
The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the individual becoming an Executive Officer.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 116 | $95.00 | $11K |
Footnotes (1)
- F1. The sale reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the Reporting Person becoming an Executive Officer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Albemarle (ALB) disclose in this Form 4?
Who is the reporting person in the ALB Form 4?
Was the ALB sale under a Rule 10b5-1 plan?
Is this Form 4 filed by one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.